drugset / Trial / NCT01075659

Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge

NCT01075659

Phase 2 Completed 200 enrolled McNeil AB
RandomizedCrossoverOpen-labelTreatment

Summary

A comparison of two products for oral nicotine replacement with respect to relief of urges to smoke after single doses of nicotine.

Timeline

Start
2010-02
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotine Unknown 2 mg
Comparator Nicotine Unknown 4 mg

Indications

No indication recorded.